REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
05/03/2021 14:05
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210305:nBw1ZHRc9a&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
Ap19
FORM 8.3 - Amendment to sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 03 March 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,830,784 1.42% 230,744 0.18%
(2) Derivatives (other than options):
153,127 0.12% 30,805 0.02%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,990,011 1.54% 267,649 0.21%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 221.7100 USD
Purchase 3 225.9266 USD
Purchase 23 223.4554 USD
Purchase 100 224.3350 USD
Purchase 100 224.6900 USD
Purchase 155 227.2474 USD
Purchase 157 222.6235 USD
Purchase 198 223.0717 USD
Purchase 200 223.1000 USD
Purchase 200 223.1550 USD
Purchase 200 222.4350 USD
Purchase 312 222.7836 USD
Purchase 380 223.0902 USD
Purchase 400 223.4000 USD
Purchase 544 223.5671 USD
Purchase 616 223.6415 USD
Purchase 732 222.8160 USD
Purchase 765 223.2616 USD
Purchase 1,022 223.7587 USD
Purchase 1,088 222.9898 USD
Purchase 1,100 226.5721 USD
Purchase 1,152 224.1878 USD
Purchase 4,727 223.1376 USD
Purchase 6,960 222.7660 USD
Purchase 7,292 223.5727 USD
Purchase 8,780 224.7236 USD
Purchase 9,398 223.9242 USD
Purchase 9,788 223.6117 USD
Purchase 15,000 222.0950 USD
Purchase 15,300 225.4989 USD
Purchase 17,584 223.3250 USD
Purchase 19,584 224.8089 USD
Purchase 22,347 222.8874 USD
Purchase 44,633 224.2220 USD
Purchase 313,248 222.6500 USD
Sale 1 223.5900 USD
Sale 3 223.5933 USD
Sale 5 223.6160 USD
Sale 11 223.3436 USD
Sale 18 222.6488 USD
Sale 92 224.8000 USD
Sale 100 223.5750 USD
Sale 100 226.3500 USD
Sale 100 226.5900 USD
Sale 100 227.4800 USD
Sale 194 225.8498 USD
Sale 200 222.4850 USD
Sale 298 226.2844 USD
Sale 300 225.5733 USD
Sale 449 224.9227 USD
Sale 451 222.4537 USD
Sale 506 225.2098 USD
Sale 507 223.9448 USD
Sale 530 222.3190 USD
Sale 549 223.3701 USD
Sale 569 223.6284 USD
Sale 720 225.7101 USD
Sale 753 225.0180 USD
Sale 773 224.1318 USD
Sale 900 226.4692 USD
Sale 1,013 223.3767 USD
Sale 1,114 223.7671 USD
Sale 1,152 224.1878 USD
Sale 1,208 225.2651 USD
Sale 1,255 225.4294 USD
Sale 1,500 223.1590 USD
Sale 1,628 226.3522 USD
Sale 1,636 223.6402 USD
Sale 3,273 225.1234 USD
Sale 3,931 223.2333 USD
Sale 4,804 225.3803 USD
Sale 5,136 224.9526 USD
Sale 5,984 224.1567 USD
Sale 6,440 222.7285 USD
Sale 6,585 223.7886 USD
Sale 6,710 223.6882 USD
Sale 9,995 224.8468 USD
Sale 13,809 225.2456 USD
Sale 13,940 224.6280 USD
Sale 15,000 222.0950 USD
Sale 16,123 223.5446 USD
Sale 16,730 223.2587 USD
Sale 46,727 223.2777 USD
Sale 311,245 222.6500 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 5 Mar 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210305005326/en/
(https://www.businesswire.com/news/home/20210305005326/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC IQE PLC - Form 8.3 IQE PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC JTC PLC - Form 8.3 JTC PLC
Announcement